Bristol-Myers Squibb and KAI Pharmaceuticals, a privately held biotechnology company, have announced an exclusive agreement for the global development and commercialization of KAI-9803.

Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in 3M Co (Symbol: MMM), where a total of 44,109 contracts have traded so far, representing ...

3M Company (NYSE:MMM) is one of the Best Dividend Stocks of 2025. The stock has delivered a nearly 14% return since the start of 2025. The company posted strong earnings in the first quarter of ...

3M Company (NYSE:MMM) is one of the defensive stocks billionaires are buying amid US trade tariff uncertainty. On July 21, UBS reiterated a ‘Buy’ rating on the stock and a $184 price target ...

3M Co (MMM) reports a 12% increase in adjusted EPS and robust shareholder returns, despite facing macroeconomic and legal hurdles.

3M Company (NYSE:MMM) is included among the 11 Innovative Dividend Stocks to Buy Now. 3M Company (NYSE:MMM) is well known for inventing Post-it Notes, which have become a common item in workplaces ...